|
1
|
Parsons DW, Jones S, Zhang X, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et
al: An integrated genomic analysis of human glioblastoma
multiforme. Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
You G, Sha ZY, Yan W, Zhang W, Wang YZ, Li
SW, Sang L, Wang Z, Li GL, Li SW, et al: Seizure characteristics
and outcomes in 508 Chinese adult patients undergoing primary
resection of low-grade gliomas: A clinicopathological study. Neuro
Oncol. 14:230–241. 2012. View Article : Google Scholar :
|
|
3
|
Dahlrot RH: The prognostic value of
clinical factors and cancer stem cell-related markers in gliomas.
Dan Med J. 61:B49442014.PubMed/NCBI
|
|
4
|
Tabatabai G and Weller M: Glioblastoma
stem cells. Cell Tissue Res. 343:459–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
D'Uva G, Bertoni S, Lauriola M, De Carolis
S, Pacilli A, D'Anello L, Santini D, Taffurelli M, Ceccarelli C,
Yarden Y, et al: Beta-catenin/HuR post-transcriptional machinery
governs cancer stem cell features in response to hypoxia. PLoS One.
8:e807422013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Korkaya H, Kim GI, Davis A, Malik F, Henry
NL, Ithimakin S, Quraishi AA, Tawakkol N, D'Angelo R, Paulson AK,
et al: Activation of an IL6 inflammatory loop mediates trastuzumab
resistance in HER2+ breast cancer by expanding the
cancer stem cell population. Mol Cell. 47:570–584. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Hu W, Xie B, Gao H, Xu C and Chen
J: Downregulation of SCAI enhances glioma cell invasion and stem
cell like phenotype by activating Wnt/β-catenin signaling. Biochem
Biophys Res Commun. 448:206–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rathod SS, Rani SB, Khan M, Muzumdar D and
Shiras A: Tumor suppressive miRNA-34a suppresses cell proliferation
and tumor growth of glioma stem cells by targeting Akt and Wnt
signaling pathways. FEBS Open Bio. 4:485–495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brabletz S, Schmalhofer O and Brabletz T:
Gastrointestinal stem cells in development and cancer. J Pathol.
217:307–317. 2009. View Article : Google Scholar
|
|
10
|
Wang H and Chen X: Tetrandrine ameliorates
cirrhosis and portal hypertension by inhibiting nitric oxide in
cirrhotic rats. J Huazhong Univ Sci Technolog Med Sci. 24:385–388.
3952004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Y, Chen JC and Tseng SH: Effects of
tetrandrine plus radiation on neuroblastoma cells. Anticancer Res.
29:3163–3171. 2009.PubMed/NCBI
|
|
12
|
Gao JL, Ji X, He TC, Zhang Q, He K, Zhao
Y, Chen SH and Lv GY: Tetrandrine suppresses cancer angiogenesis
and metastasis in 4T1 tumor bearing mice. Evid Based Complement
Alternat Med. 2013:2650612013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho HS, Chang SH, Chung YS, Shin JY, Park
SJ, Lee ES, Hwang SK, Kwon JT, Tehrani AM, Woo M, et al:
Synergistic effect of ERK inhibition on tetrandrine-induced
apoptosis in A549 human lung carcinoma cells. J Vet Sci. 10:23–28.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu K, Zhou M, Wu QX, Yuan SX, Wang DX, Jin
JL, Huang J, Yang JQ, Sun WJ, Wan LH, et al: The role of IGFBP-5 in
mediating the anti-proliferation effect of tetrandrine in human
colon cancer cells. Int J Oncol. 46:1205–1213. 2015.
|
|
15
|
Kou B, Liu W, He W, Zhang Y, Zheng J, Yan
Y, Zhang Y, Xu S and Wang H: Tetrandrine suppresses metastatic
phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9
signaling pathway. Oncol Rep. 35:2880–2886. 2016.PubMed/NCBI
|
|
16
|
Kida K, Ishikawa T, Yamada A, Shimada K,
Narui K, Sugae S, Shimizu D, Tanabe M, Sasaki T, Ichikawa Y, et al:
Effect of ALDH1 on prognosis and chemoresistance by breast cancer
subtype. Breast Cancer Res Treat. 156:261–269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gehlot P, Shukla V, Gupta S and Makidon
PE: Detection of ALDH1 activity in rabbit hepatic VX2 tumors and
isolation of ALDH1 positive cancer stem cells. J Transl Med.
14:492016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Wang SX, Ma JW, Li HY, Ye JC, Xie
SM, Du B and Zhong XY: EGCG inhibits properties of glioma stem-like
cells and synergizes with temozolomide through downregulation of
P-glycoprotein inhibition. J Neurooncol. 121:41–52. 2015.
View Article : Google Scholar
|
|
19
|
Nakahata K, Uehara S, Nishikawa S, Kawatsu
M, Zenitani M, Oue T and Okuyama H: Aldehyde dehydrogenase 1
(ALDH1) is a potential marker for cancer stem cells in embryonal
rhabdomyosarcoma. PLoS One. 10:e01254542015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu M, Inoue K, Leng T, Guo S and Xiong
ZG: TRPM7 channels regulate glioma stem cell through STAT3 and
Notch signaling pathways. Cell Signal. 26:2773–2781. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Venugopal A, Subramaniam D, Balmaceda J,
Roy B, Dixon DA, Umar S, Weir SJ and Anant S: RNA binding protein
RBM3 increases beta-catenin signaling to increase stem cell
characteristics in colorectal cancer cells. Mol Carcinog.
55:1503–1516. 2015. View
Article : Google Scholar
|
|
22
|
Gong A and Huang S: FoxM1 and
Wnt/β-catenin signaling in glioma stem cells. Cancer Res.
72:5658–5662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim KH, Seol HJ, Kim EH, Rheey J, Jin HJ,
Lee Y, Joo KM, Lee J and Nam DH: Wnt/β-catenin signaling is a key
downstream mediator of MET signaling in glioblastoma stem cells.
Neuro Oncol. 15:161–171. 2013. View Article : Google Scholar
|
|
24
|
Shi L, Fei X, Wang Z and You Y: PI3K
inhibitor combined with miR-125b inhibitor sensitize TMZ-induced
anti-glioma stem cancer effects through inactivation of
Wnt/beta-catenin signaling pathway. In Vitro Cell Dev Biol Anim.
51:1047–1055. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhagya N and Chandrashekar KR: Tetrandrine
- A molecule of wide bioactivity. Phytochemistry. 125:5–13. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu XH, Gan YC, Xu GB, Chen T, Zhou H, Tang
JF, Gu Y, Xu F, Xie YY, Zhao XY, et al: Tetrandrine citrate
eliminates imatinib-resistant chronic myeloid leukemia cells in
vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. J Zhejiang
Univ Sci B. 13:867–874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim
SH, Huang E, Gao Y, Yang K, Wagner ER, et al: Tetrandrine inhibits
Wnt/β-catenin signaling and suppresses tumor growth of human
colorectal cancer. Mol Pharmacol. 79:211–219. 2011. View Article : Google Scholar :
|
|
28
|
Zhang YX, Liu XM, Wang J, Li J, Liu Y,
Zhang H, Yu XW and Wei N: Inhibition of AKT/FoxO3a signaling
induced PUMA expression in response to p53-independent cytotoxic
effects of H1: A derivative of tetrandrine. Cancer Biol Ther.
16:965–975. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu R, Liu T, Tan Z, Wu X, Li M, Jiang L,
Bao R, Shu Y, Lu A and Liu Y: Tetrandrine induces apoptosis in
gallbladder carcinoma in vitro. Int J Clin Pharmacol Ther.
52:900–905. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu VW and Ho WS: Tetrandrine inhibits
hepatocellular carcinoma cell growth through the caspase pathway
and G2/M phase. Oncol Rep. 29:2205–2210. 2013.PubMed/NCBI
|
|
31
|
Zheng H, Ying H, Wiedemeyer R, Yan H,
Quayle SN, Ivanova EV, Paik JH, Zhang H, Xiao Y, Perry SR, et al:
PLAGL2 regulates Wnt signaling to impede differentiation in neural
stem cells and gliomas. Cancer Cell. 17:497–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Náger M, Santacana M, Bhardwaj D, Valls J,
Ferrer I, Nogués P, Cantí C and Herreros J: Nuclear phosphorylated
Y142 β-catenin accumulates in astrocytomas and glioblastomas and
regulates cell invasion. Cell Cycle. 14:3644–3655. 2015. View Article : Google Scholar
|
|
33
|
Kahlert UD, Suwala AK, Koch K, Natsumeda
M, Orr BA, Hayashi M, Maciaczyk J and Eberhart CG: Pharmacologic
Wnt inhibition reduces proliferation, survival, and clonogenicity
of glioblastoma cells. J Neuropathol Exp Neurol. 74:889–900. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang N, Wei P, Gong A, Chiu WT, Lee HT,
Colman H, Huang H, Xue J, Liu M, Wang Y, et al: FoxM1 promotes
β-catenin nuclear localization and controls Wnt target-gene
expression and glioma tumorigenesis. Cancer Cell. 20:427–442. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar
|
|
37
|
Chenn A and Walsh CA: Regulation of
cerebral cortical size by control of cell cycle exit in neural
precursors. Science. 297:365–369. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Clevers H, Loh KM and Nusse R: Stem cell
signaling. An integral program for tissue renewal and regeneration:
Wnt signaling and stem cell control. Science. 346:12480122014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nusse R: Wnt signaling and stem cell
control. Cell Res. 18:523–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kierulf-Vieira KS, Sandberg CJ, Grieg Z,
Günther CC, Langmoen IA and Vik-Mo EO: Wnt inhibition is
dysregulated in gliomas and its re-establishment inhibits
proliferation and tumor sphere formation. Exp Cell Res. 340:53–61.
2016. View Article : Google Scholar
|
